AMRA Medical, in collaboration with the University of Oslo, has published a study examining the effects of antidepressants (ADs), particularly serotonin-selective reuptake inhibitors (SSRIs) and tricyclic antidepressants (TCAs), on muscle health and cardiometabolic risk. Conducted as part of the CoMorMent…
AptarGroup, Inc. (NYSE: ATR), a global leader in dosing, dispensing, and protection technologies for drug and consumer products, has announced the award of a contract from the U.S. Federal Government to further develop its ActivShield™ technology. This innovative solution enables…
Pfizer Inc. (NYSE: PFE) announced that the U.S. Food and Drug Administration (FDA) has approved ABRYSVO® (Respiratory Syncytial Virus Vaccine), a bivalent RSV vaccine, for preventing lower respiratory tract disease (LRTD) caused by RSV in individuals aged 18 to 59…
Hello Heart, a leader in preventive heart health, has announced its expansion into government markets across the United States. This initiative aims to make its proven heart health tools accessible to millions of Americans, allowing them to manage their health…
Hesperos, Inc., a leader in human biology modeling for drug development through its Human-on-a-Chip® technology, is excited to announce the appointment of Lawrence (Larry) Florin as Chief Executive Officer. With over 20 years of leadership experience in bio and clinical…
Alto Neuroscience, Inc. (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on innovative treatments for neuropsychiatric disorders, announced today that its Phase 2b trial of ALTO-100 for major depressive disorder (MDD) did not achieve its primary endpoint, as measured by the…
Medpace Holdings, Inc. (Nasdaq: MEDP) has announced its financial results for the third quarter ending September 30, 2024. Third Quarter 2024 Financial Highlights Year-to-Date 2024 Financial Overview Balance Sheet and Liquidity As of September 30, 2024, Medpace had cash and…
According to the report “Health 2035: A Bold Path Through the Uncharted Future of Health,” published by HSBC Innovation Banking and The Linus Group, meaningful change in healthcare requires enhanced trust between physicians and patients, a reimagining of in-person interactions,…
Vivasure Medical®, a leader in fully absorbable technology for percutaneous vessel closure, will reveal the findings from its U.S. PATCH Study at the Transcatheter Cardiovascular Therapeutics (TCT) 2024 conference in Washington, D.C., from October 27-30, 2024. The study evaluates the…
GE HealthCare (Nasdaq: GEHC) has introduced CareIntellect for Oncology, a new cloud-based application that consolidates multi-modal patient data from various systems into a single, streamlined view. Utilizing generative AI, the application summarizes clinical notes and reports, enabling care teams to…
